Blog

AirJoule Technologies Corporation AIRJ is slated to report its fourth-quarter 2025 results on March 30, after the closing bell.

The company’s earnings surprise history is impressive. It surpassed

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider TD SYNNEX

Rave Restaurant Group, Inc. RAVE investors have been experiencing some short-term losses from the stock in recent months. Shares of this Dallas, TX-based operator of pizza restaurants have declined

BrightSpring Health Services, Inc. BTSG is coming off a strong finish to 2025, and the market is rewarding that momentum. The stock now trades at 24.5 times forward 12-month earnings per share

BrightSpring Health Services, Inc. BTSG is built around a durable healthcare shift: more complex care moving out of hospitals and into the home and community. The company’s 2026 setup pairs that

BrightSpring Health Services, Inc. BTSG enters 2026 with a business model built for one clear trend: more complex care moving out of hospitals and into the home. That shift expands demand for

Bristol Myers Squibb BMY recently won FDA and European Commission (EC) approvals for the label expansion of its blockbuster immuno-oncology (IO) drug Opdivo.

The FDA approved Opdivo in combination

PG&E (PCG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most

BCB Bancorp (BCBP) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Investors might want to bet on CMS Energy (CMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

First Bancorp (FBNC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Investors might want to bet on RF Industries, Ltd. (RFIL), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Magnolia Oil & Gas Corp (MGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Coherus Oncology (CHRS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Enbridge (ENB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most

Investors might want to bet on EQT Corporation (EQT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Investors might want to bet on Equinox Gold (EQX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

The going has been strong for Regeneron Pharmaceuticals REGN over the past six months. Shares of this biotech giant have surged 31.5% in this time frame, outpacing the industry’s growth of 13.5%

Archrock Inc. AROC is a leading natural gas compression services provider that supports gas production, processing and transportation. The company has a stable business model, backed by fee-based

Humana Inc. HUM benefits from a strong care delivery model centered on value-based care, increasing premiums, strategic acquisitions, an aging population in the United States and solid cash

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from